Jamie Smith
Media Relations
Email: jamie.smith@molnlycke.com
Phone: +46 722-553573

Gothenburg, Sweden. 13 October 2026. No two pairs of hands are the same, yet surgical glove sizing has changed little over time. Mölnlycke Health Care (Mölnlycke®), a global leader in MedTech, has listened to what clinicians are saying and is now launching an expanded range of surgical glove fit options. MyFit™ by Biogel® is designed to better reflect the diversity of clinicians’ hand anatomy and help more healthcare professionals find a glove that supports comfort, safety and performance – all critical in the operating room.
New research shows that one in three (32%) surgical glove users with smaller hands want better-fitting or more customised glove sizing options.1 Wider research also highlights the challenge of glove fit for women, with nearly half (44%) reporting that their current glove size is not a good fit.2
In surgery, millimetres matter. Poorly fitting gloves can affect both comfort and performance. Excess material in the fingertips may reduce tactile sensitivity and dexterity, while tightness across the palm can limit hand movement.3, 4 These issues may also increase the risk of glove breaches during surgery, with potential implications for operating room safety protocols.5
Traditional surgical glove sizing relies primarily on palm width measurements and often fails to account for differences in finger length and hand anatomy, forcing many clinicians to compromise between palm comfort and fingertip precision.1, 2
“Hands are a surgeon’s most important instrument in the operating room. The right glove fit is not a nice-to-have; it is critical to comfort, safety and performance. More inclusive sizing means fewer surgical team members have to settle for gloves that do not support them at their best,” says Dr. Abhishek Chatterjee, Chief of Plastic Surgery at Tufts Medical Center, Massachusetts, USA, and the lead author of a 2025 systematic literature review on surgical glove fit and provider performance.3
Developed using extensive research and 3D hand measurement data from 780 clinicians,6 MyFit™ by Biogel® offers more options for clinicians who fall between standard sizes or outside conventional fit profiles.
“For more than 40 years, Biogel® has been trusted by surgical teams around the world. With MyFit™ by Biogel®, we are taking the next step by offering sizing options that better reflect the diversity of clinicians’ hands, so more people can work with confidence, comfort and control,” says Katriina Öberg, Executive Vice President Gloves at Mölnlycke Health Care.
Learn more about MyFit™ by Biogel®
For more information, please contact:

Media Relations
Email: jamie.smith@molnlycke.com
Phone: +46 722-553573
About Mölnlycke
Mölnlycke Health Care is a world-leading MedTech company specialising in innovative solutions for wound care and surgical procedures. Mölnlycke products and solutions are used daily by hospitals, health care providers and patients in over 100 countries worldwide. Founded in 1849, Mölnlycke is owned by Patricia Industries, part of Investor AB, and is headquartered in Sweden.
Mölnlycke has joined the American Limb Preservation Society (ALPS) as an official Gold Strategic Partner, reinforcing a shared commitment to improving outcomes for patients at risk of amputation due to diabetic foot complications.
At Mölnlycke Health Care, we work alongside clinicians, researchers and healthcare experts to advance evidence-based care and help raise standards for post-operative care.
Gothenburg, Sweden. 21 September 2026. Mölnlycke Health Care (Mölnlycke®), a global leader in MedTech, today announces the launch of The Hidden Capacity Report, a new international report revealing significant opportunities to expand day surgery and help healthcare systems improve efficiency, increase surgical throughput and enhance patient outcomes.
Gothenburg, Sweden. 16 September 2026. Mölnlycke®, a global leader in MedTech, announces its intention to separate its Operating Room Solutions (ORS) and Gloves businesses into a new standalone company (referred to here as “Mölnlycke Surgical”). The separation is intended to create conditions for both Mölnlycke and Mölnlycke Surgical to reach their full potential and drive value creation long-term.
UK’s Largest Hip and Knee Replacement Centre Becomes First in Scotland to Adopt Steriwave® Nasal Photodisinfection.
Gothenburg, Sweden. 8 June 2026. Mölnlycke Health Care (“Mölnlycke®”), a global leader in MedTech, today confirmed a combined investment of approximately EUR 40 million in Mikkeli, Finland, and Oldham, UK. The investments strengthen the company’s global wound care manufacturing network by increasing capacity, optimising process quality and enhancing supply chain resilience and sustainability.
Gothenburg, Sweden. 23 June 2026. Mölnlycke Health Care (Mölnlycke®), a global leader in MedTech, today announces changes to its Board of Directors. Christian Cederholm will leave his Board assignment, while Filippa Stenberg will take his place as member of the Board. Thomas Kidane will step in as deputy board member.
Mölnlycke has completed construction of its first manufacturing facility in China, marking a major milestone in the company's growth journey and strengthening its ability to serve one of the world's largest and fastest growing healthcare markets.